Related Experiment Video
Updated: May 4, 2026

05:39
Spontaneous Murine Model of Anaplastic Thyroid Cancer
Published on: February 3, 2023
2.1K
Multiple endocrine neoplasia type 2A: case report
Summary
Multiple endocrine neoplasia type 2A (MEN 2A) is an inherited syndrome. Genetic analysis in one family revealed a RET gene mutation in a father and daughter, with earlier onset in the daughter, suggesting anticipation.
Area of Science:
- Genetics
- Endocrinology
- Oncology
Background:
- Multiple endocrine neoplasia type 2A (MEN 2A) is an autosomal dominant inherited disorder.
- It is characterized by medullary thyroid carcinoma (MTC), pheochromocytoma, and parathyroid hyperplasia.
- Diagnosis often requires identifying germline RET mutations or family history when clinical features are incomplete.
Observation:
- A family with MEN 2A syndrome was investigated.
- Genetic analysis identified a RET gene mutation at codon 634 in both a 48-year-old father and his 20-year-old daughter.
- The daughter was the initial case, diagnosed with pheochromocytoma at age 19, with the father diagnosed later with MTC.
Findings:
- The study confirmed MEN 2A in the family through genetic testing.
- A specific RET gene mutation (codon 634) was identified in affected father and daughter.
- The daughter presented with earlier onset and a different initial manifestation (pheochromocytoma) compared to the father (MTC).
Implications:
- This case highlights the importance of genetic screening in families with suspected MEN 2A.
- The findings support the phenomenon of anticipation in MEN 2A, where successive generations exhibit earlier onset and increased severity.
- Earlier diagnosis and intervention are crucial, especially given the potential for worse prognosis in earlier-onset cases.
Related Concept Videos
Cushing Syndrome II: Pathophysiology
24
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features...
24
Type II Diabetes II: Pathophysiology
28
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
28
Hyperthyroidism II: Pathophysiology
28
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH...
28
Type II Diabetes I: Introduction
17
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
17
